Related Experiment Video
Updated: May 27, 2026
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
What can and cannot be done using a microarray analysis? Treatment stratification and clinical applications in
Tokuzo Arao1, Kazuko Matsumoto, Mari Maegawa
1Department of Genome Biology, Faculty of Medicine, Kinki University, Osaka, Japan.
Biological & Pharmaceutical Bulletin
|December 2, 2011
Summary
Microarray analysis is crucial for identifying biomarkers for molecular-targeted cancer drugs. This study discusses its application in treatment stratification, focusing on epidermal growth factor receptor (EGFR) and fibroblast growth factor receptor 2 (FGFR2).
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Biomarker Discovery
Background:
- Microarray technology has matured, offering reliable and reproducible gene expression measurements.
- While technical aspects are resolved, clinically validated biomarkers for molecular-targeted drugs using microarrays are lacking.
- Existing multigene assays like OncotypeDX and MammaPrint demonstrate the potential of gene expression profiling for treatment decisions.
Purpose of the Study:
- To explore the utility of microarray analysis in identifying biomarkers for molecular-targeted cancer therapies.
- To discuss the application of gene expression profiles for treatment stratification and clinical decision-making.
- To present data on mutant epidermal growth factor receptor (EGFR) signaling and fibroblast growth factor receptor 2 (FGFR2) amplification.
Main Methods:
- Utilized microarray analysis to assess gene expression profiles.
- Investigated mutant epidermal growth factor receptor (EGFR) signaling pathways.
- Analyzed fibroblast growth factor receptor 2 (FGFR2) amplification in clinical samples.
Main Results:
- Demonstrated the capability of microarray analysis to detect specific genetic alterations like EGFR mutations and FGFR2 amplification.
- Highlighted the potential of gene expression data for stratifying patients for targeted therapies.
- Provided insights into the role of microarray data in early-phase clinical trials for molecular-targeted drugs.
Conclusions:
- Microarray analysis holds significant promise for discovering clinically relevant biomarkers for molecular-targeted cancer treatments.
- Gene expression profiling via microarrays can aid in treatment stratification and inform clinical applications.
- Further development of multigene expression assays is anticipated, building on successful models.
Related Concept Videos
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...